Monday, 02 February 2026 05:20 AM Umbrella Labs Cagrilintide Peptide Research Use Only Program Expands Laboratory Access For High Rigor Amylin Receptor, Calcitonin Receptor, And Neuroendocrine Signaling Bench Science Monday, 02 February 2026 05:20 AM Company Update TUCSON, AZ / ACCESS Newswire / February 2, 2026 / Umbrella Labs today announced an expanded research procurement program for cagrilintide peptide to support laboratories running amylin receptor complex profiling, calcitonin receptor signaling studies, and neuroendocrine pathway mapping in controlled bench environments
The clearance rate of Dihexa was compared to those of similar nootropic compounds such as piroxicam, verapamil, and 7-ethoxycoumarin [2]
In addition, nattokinase was not associated with any adverse reactions or drug interactions (Gallelli 2021)
*Store lyophilized peptide at 20 C in a dry, dark location *Avoid repeated freezethaw cycles *Protect from prolonged exposure to light Description BPC-157 (Body Protection Compound-157) is a synthetic peptide consisting of 15 amino acids and is supplied as a lyophilized peptide powder for laboratory research and analytical applications
This product is not a drug, dietary supplement, or medical treatment